Cardiovascular effects of atomoxetine in children, adolescents, and adults.

@article{Wernicke2003CardiovascularEO,
  title={Cardiovascular effects of atomoxetine in children, adolescents, and adults.},
  author={Joachim Wernicke and Douglas E. Faries and Donald A. Girod and Jeffrey Brown and Haitao Gao and Douglas Kelsey and Humberto Quintana and Robert S Lipetz and D. Michelson and John H. Heiligenstein},
  journal={Drug safety},
  year={2003},
  volume={26 10},
  pages={
          729-40
        }
}
BACKGROUND Atomoxetine is a highly specific presynaptic inhibitor of the noradrenaline (norepinephrine) transporter that was recently approved in the US for the treatment of patients with attention-deficit/hyperactivity disorder (ADHD). Adverse effects on the cardiovascular system, including abnormalities in heart rate, blood pressure, or cardiac rhythm have been associated with several noradrenergic medications. OBJECTIVE To further elucidate the magnitude and impact of blood pressure and… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

Similar Papers

Loading similar papers…